We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03064490
Brief Title: Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED) (PROCEED)

First Submitted : February 22, 2017
First Submitted that Met QC Criteria : February 24, 2017
First Posted : February 27, 2017

Last Update Submitted that Met QC Criteria : December 7, 2022
Last Update Posted : December 8, 2022